Last Updated: September 24, 2026

TRAZODONE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Trazodone Hydrochloride, and when can generic versions of Trazodone Hydrochloride launch?

Trazodone Hydrochloride is a drug marketed by Accord Hlthcare, Aiping Pharm Inc, Alvogen, Am Therap, Apotex, Apotex Inc, Aurobindo Pharma, Crossmedika Sa, Granules, Graviti Pharms, Natco, Oxford Pharms, Pharmobedient, Pliva, Quantum Pharmics, Rising, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent, Usl Pharma, Watson Labs, and Zydus Pharms. and is included in thirty-two NDAs.

The generic ingredient in TRAZODONE HYDROCHLORIDE is trazodone hydrochloride. There is one drug master file entry for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Trazodone Hydrochloride

A generic version of TRAZODONE HYDROCHLORIDE was approved as trazodone hydrochloride by APOTEX on March 25th, 1987.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for TRAZODONE HYDROCHLORIDE?
  • What are the global sales for TRAZODONE HYDROCHLORIDE?
  • What is Average Wholesale Price for TRAZODONE HYDROCHLORIDE?
Recent Clinical Trials for TRAZODONE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VA Office of Research and DevelopmentPHASE4
University of UtahPHASE4
Massachusetts General HospitalPHASE4

See all TRAZODONE HYDROCHLORIDE clinical trials

Pharmacology for TRAZODONE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for TRAZODONE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TRAZODONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for TRAZODONE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
DESYREL Tablets trazodone hydrochloride 25 mg and 75 mg 018207 1 2026-07-27
RALDESY Oral Solution trazodone hydrochloride 10 mg/mL 218637 1 2026-06-17
OLEPTRO Extended-release Tablets trazodone hydrochloride 150 mg and 300 mg 022411 1 2010-10-18

US Patents and Regulatory Information for TRAZODONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 073137-002 Mar 24, 1993 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Oxford Pharms TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 072192-001 Feb 2, 1989 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Torrent TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 202180-003 Nov 27, 2013 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Pharms TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 205253-004 Oct 10, 2017 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva Pharms Usa TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 071523-001 Dec 11, 1987 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Torrent TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 202180-004 Nov 27, 2013 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.